S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSE:INSP

Inspire Medical Systems (INSP) Stock Price, News & Analysis

$215.02
+1.52 (+0.71%)
(As of 03/28/2024 ET)
Today's Range
$214.00
$223.40
50-Day Range
$177.50
$226.00
52-Week Range
$123.27
$330.00
Volume
614,184 shs
Average Volume
521,464 shs
Market Capitalization
$6.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$271.29

Inspire Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
26.3% Upside
$271.29 Price Target
Short Interest
Bearish
6.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.70mentions of Inspire Medical Systems in the last 14 days
Based on 14 Articles This Week
Insider Trading
Selling Shares
$4 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.35) to $0.58 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.71 out of 5 stars

Medical Sector

56th out of 938 stocks

Surgical & Medical Instruments Industry

10th out of 97 stocks

INSP stock logo

About Inspire Medical Systems Stock (NYSE:INSP)

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

INSP Stock Price History

INSP Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Inspire Medical Systems (NYSE:INSP) Given Buy Rating at Mizuho
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Leerink Partners Remains a Hold on Inspire Medical Systems (INSP)
INSP Apr 2024 150.000 call
Edifecs to Speak at RISE National 2024
No waiting line for vets' care
INSP Jan 2025 185.000 call
INSP Dec 2024 135.000 put
See More Headlines
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/06/2024
Today
3/28/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
1,011
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$271.29
High Stock Price Target
$371.00
Low Stock Price Target
$159.00
Potential Upside/Downside
+26.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$-21,150,000.00
Pretax Margin
-3.19%

Debt

Sales & Book Value

Annual Sales
$624.80 million
Book Value
$19.39 per share

Miscellaneous

Free Float
29,055,000
Market Cap
$6.52 billion
Optionable
Optionable
Beta
1.35
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

INSP Stock Analysis - Frequently Asked Questions

Should I buy or sell Inspire Medical Systems stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" INSP shares.
View INSP analyst ratings
or view top-rated stocks.

What is Inspire Medical Systems' stock price target for 2024?

13 Wall Street research analysts have issued twelve-month price objectives for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they predict the company's share price to reach $271.29 in the next year. This suggests a possible upside of 26.3% from the stock's current price.
View analysts price targets for INSP
or view top-rated stocks among Wall Street analysts.

How have INSP shares performed in 2024?

Inspire Medical Systems' stock was trading at $203.43 at the start of the year. Since then, INSP shares have increased by 5.6% and is now trading at $214.79.
View the best growth stocks for 2024 here
.

Are investors shorting Inspire Medical Systems?

Inspire Medical Systems saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,870,000 shares, an increase of 6.9% from the February 29th total of 1,750,000 shares. Based on an average daily volume of 512,300 shares, the days-to-cover ratio is currently 3.7 days.
View Inspire Medical Systems' Short Interest
.

When is Inspire Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our INSP earnings forecast
.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) announced its quarterly earnings results on Tuesday, February, 6th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.53. The business had revenue of $192.51 million for the quarter, compared to the consensus estimate of $186.75 million. Inspire Medical Systems had a negative net margin of 3.39% and a negative trailing twelve-month return on equity of 3.93%. The company's revenue for the quarter was up 39.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.10 EPS.

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $775.0 million-$785.0 million, compared to the consensus revenue estimate of $780.3 million.

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

Inspire Medical Systems (INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.91%), Vanguard Group Inc. (9.91%), Wellington Management Group LLP (4.84%), Baillie Gifford & Co. (4.17%), Wasatch Advisors LP (3.71%) and Frontier Capital Management Co. LLC (2.51%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends
.

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:INSP) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners